Melinta Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2000-01-01
- Employees
- 290
- Market Cap
- -
- Website
- http://melinta.com
Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-07-22
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT00719810
- Locations
- 🇺🇸
Riverside Methodist Hospital, Columbus, Ohio, United States
🇺🇸Physician Alliance Research Center, Anaheim, California, United States
🇺🇸Tri City Medical Center, Oceanside, California, United States
Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-03-31
- Last Posted Date
- 2014-03-27
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT00646958
- Locations
- 🇺🇸
Jamaica Hospital Medical Center, Jamaica, New York, United States
🇺🇸Mercury Street Medical Group, LLC, Butte, Montana, United States
🇺🇸Healthcare Partners Medical Group, Los Angeles, California, United States
Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- Melinta Therapeutics, Inc.
- Target Recruit Count
- 158
- Registration Number
- NCT00640926
- Locations
- 🇨🇦
Westview Research, North Vancouver, British Columbia, Canada
🇺🇸Mercury Street Medical Group, LLC, Butte, Montana, United States
🇨🇦Ronald Collette, MD, Burnaby, British Columbia, Canada
© Copyright 2024. All Rights Reserved by MedPath